Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Fatigue, depression, and health-related quality of life in patients with multiple sclerosis in Isfahan, Iran.
Myelinating and demyelinating phenotype of Trembler-J mouse (a model of Charcot-Marie-Tooth human disease) analyzed by atomic force microscopy and confocal microscopy.
Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases.
The hGFAP-driven conditional TSPO knockout is protective in a mouse model of multiple sclerosis.
Extracellular Vesicles and a Novel Form of Communication in the Brain.
Omega-3 Fatty Acids for Depression in Multiple Sclerosis: A Randomized Pilot Study.
A white matter lesion-filling approach to improve brain tissue volume measurements.
Emerging functions of the Quaking RNA-binding proteins and link to human diseases.
Considering depression as a consequence of activation of the inflammatory response system.
New insights into the role of stromal cell-derived factor 1 (SDF-1/CXCL12) in the pathophysiology of multiple sclerosis.
Spatial and temporal characteristics of gait as outcome measures in multiple sclerosis (EDSS 0 to 6.5).
NCF1 gene and pseudogene pattern: association with parasitic infection and autoimmunity.
Levodopa-responsive Holmes' Tremor Caused by a Single Inflammatory Demyelinating Lesion.
Cortical lesion counts by double inversion recovery should be part of the MRI monitoring process for all MS patients: No.
[The results of an open prospective study of β-interferon biosimilars (an Yaroslavl' cohort)].
Anxiety, depression and fatigue at 5-year review following CNS demyelination.
Editorial: Cytokines as Players of Neuronal Plasticity and Sensitivity to Environment in Healthy and Pathological Brain.
Emery-Dreifuss muscular dystrophy type 2 associated (?) with mild peripheral polyneuropathy.
Human myelin proteome and comparative analysis with mouse myelin.
The use of laboratory gait analysis for understanding gait deterioration in people with multiple sclerosis.
Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease.
The topographical model of multiple sclerosis: A dynamic visualization of disease course.
Fatigue, Pain, Anxiety and Depression in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Therapeutic depletion of monocyte-derived cells protects from long-term axonal loss in experimental autoimmune encephalomyelitis.
NADPH oxidase 2 (NOX2) enzyme activation in patients with chronic inflammatory demyelinating polyneuropathy.
Pages
« first
‹ previous
…
679
680
681
682
683
684
685
686
687
…
next ›
last »